|
SJP half way there at 45 Park Avenue.
Real Estate Weekly
|
January 31, 2007
|
COPYRIGHT 2007 Hagedorn Publication. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
SJP Residential Properties, developers of 45 Park Avenue, announced the building is more the 50% sold, an important sales milestone for the new luxury condominium located on the corner of 37th Street and Park Avenue.
Allen Goldman, president of SJP Residential Properties, made the announcement.
"The sales success of 45 Park Avenue further demonstrates the excellent appeal and value of this newly-constructed condominium, located in one of the City's most exclusive residential avenues," said Goldman.
"The convenient and accessible location, ...
 "San Jose Mercury News (San Jose, CA)")
|
Gilead expands to new markets: BAY AREA MAKER OF HIV DRUGS SEEKS ADDED REVENUE SOURCES.
Newspaper article from: San Jose Mercury News (San Jose, CA)
; ...shifting away from HIV drugs, of course. Gilead Sciences of Foster City hopes to take...its drug Ambrisentan for hypertension. Gilead obtained the medicine and two other potential...people with cystic fibrosis breathe. Gilead also hopes to expand its presence in the...
|
|
Gilead Sciences and NeXstar Pharmaceuticals Announce Date for Special Stockholders Meetings to Approve Merger.
Business Wire
; ...and Boulder, Colo., on July 29, 1999 Gilead Sciences, Inc. (Nasdaq: GILD) and...matters related to the proposed merger of Gilead Sciences and NeXstar Pharmaceuticals has been set for Thursday, July 29, 1999. Gilead stockholders will meet at 11:00 a...
|
|
|
Gilead and Roche End Tamiflu(R) Dispute; Expanded Collaboration Includes Gilead Role in Oversight of Manufacturing and Commercialization.
Business Wire
; FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) and...growing incidence of avian influenza, Gilead and Roche have reached this settlement...influenza A and B, was invented by Gilead and licensed to Roche in 1996. The...
|
|
|
Gilead Signs Inventory Management Agreements with the Three Major U.S. Wholesalers.
Business Wire
; FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today...percent of the portfolio of products Gilead sells in the United States. These agreements...customer demand. Under these agreements, Gilead has agreed to pay the wholesalers a...
|
|
|
Gilead Sciences to Acquire Degussa's Raylo Chemicals Inc.; Purchase to Expand Gilead's Manufacturing Scale-Up Capacity for Investigational Therapies.
Business Wire
; FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today...signed a definitive agreement under which Gilead plans to acquire Canadian subsidiary...subject to certain closing conditions, Gilead will pay approximately 115.2 million...
|
|
|
Gilead Announces Fourth Quarter and 1998 Year-End Financial Results.
Business Wire
; ...BW HealthWire)--Jan. 27, 1999--Gilead Sciences, Inc. (NASDAQ:GILD) announced...R) (cidofovir injection), which Gilead markets independently in the United States...were contract revenue from the sale of Gilead's antisense patent estate, research...
|
|
|
Gilead Broadens HIV Expanded Access Program for PREVEON; CD4 Count and HIV RNA Level Requirements Removed and Second Dose Level Added.
Business Wire
; ...BW HealthWire)--April 2, 1998--Gilead Sciences, Inc. (NASDAQ:GILD) announced...people with limited treatment options. "Gilead worked closely with community advocates...President and Chief Executive Officer of Gilead. "We have now broadened the program...
|
|
|
Gilead Sciences Announces Appointment of John C. Martin to the Newly Created Position of Chief Operating Officer.
Business Wire
; ...BUSINESS WIRE)--Nov. 10, 1995--Gilead Sciences, Inc. (Nasdaq: GILD) announced...the appointment, Dr. Michael Riordan, Gilead's Chairman and President, stated...majority of the Company since he joined the Gilead team five years ago and has led the development...
|
|
|
Gilead Sciences to Acquire Triangle Pharmaceuticals for $464 Million.
Business Wire
; ...BUSINESS WIRE)--Dec. 4, 2002 Gilead to Launch Coviracil(R) in 2003; Will...Formulation of Viread(R) and Coviracil Gilead Sciences, Inc. (Nasdaq:GILD) and...signed a definitive agreement under which Gilead plans to acquire Triangle. The transaction...
|
|
|
Gilead Announces Initiation of Phase I/II Clinical Trial Evaluating HIV Integrase Inhibitor GS 9137.
Business Wire
; FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced...discovered by Japan Tobacco, Inc (JT) and licensed to Gilead in March 2005. The license granted Gilead exclusive rights to develop and commercialize GS 9137...
|
Find more facts and information related to the
article "SJP half way there at 45 Park Avenue."
